Unichem Laboratories Limited has informed the Exchange regarding a press release dated February 19, 2021, titled "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem s Apremilast Tablets, 10 mg, 20 mg and 30 mg.".